We have developed a drug treatment based on existing, safe, and inexpensive drugs (Darlin and Etofen – or their generic names: propranolol and etodolac) that blocks the unwanted effects of inflammatory and stress factors. In animal studies, we have shown, in six different types of cancer, that these drug treatments given around the time of surgery prevents metastases and saves lives after removal of the primary cancerous tumor. In humans, we have already conducted two small studies that have shown the safety of the treatment and promising results at the level of the cancer tissue and the prevention of bowel cancer recurrence after five years.

We are now testing the treatment on a large scale in several medical centers, with the goal of showing that it will prevent recurrence of metastases after surgery and save lives.